Philippe Wolgen serves as the Chief Executive Officer of Clinuvel Pharmaceuticals Ltd, a role he has held for over two decades. His leadership at CLINUVEL has focused on developing a unique path in biopharma, transitioning the company into a globally respected life sciences entity.

Wolgen's mission centers on delivering photoprotective pharmaceutical solutions to patients and creating enduring value for investors.